La situation europ\u00e9enne en mati\u00e8re de drogues : Une infographie interactive<\/title>\r\n <script src=\"https:\/\/cdn.tailwindcss.com\"><\/script>\r\n <script src=\"https:\/\/cdn.jsdelivr.net\/npm\/chart.js\"><\/script>\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\r\n <link href=\"https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@400;600;700&display=swap\" rel=\"stylesheet\">\r\n <style>\r\n #drug-infographic-container body {\r\n font-family: 'Inter', sans-serif;\r\n }\r\n #drug-infographic-container .chart-container {\r\n position: relative;\r\n width: 100%;\r\n max-width: 600px;\r\n margin-left: auto;\r\n margin-right: auto;\r\n height: 350px;\r\n max-height: 400px;\r\n }\r\n @media (min-width: 768px) {\r\n #drug-infographic-container .chart-container {\r\n height: 400px;\r\n }\r\n }\r\n #drug-infographic-container .stat-card {\r\n background-color: #ffffff;\r\n border-radius: 0.75rem;\r\n padding: 1.5rem;\r\n box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -2px rgba(0, 0, 0, 0.1);\r\n text-align: center;\r\n border-left: 5px solid #005f73;\r\n }\r\n #drug-infographic-container .stat-number {\r\n font-size: 2.5rem;\r\n font-weight: 700;\r\n color: #001219;\r\n }\r\n #drug-infographic-container .stat-label {\r\n font-size: 1rem;\r\n color: #0a9396;\r\n margin-top: 0.5rem;\r\n }\r\n #drug-infographic-container .section-title {\r\n font-size: 2.25rem;\r\n font-weight: 700;\r\n color: #001219;\r\n margin-bottom: 1rem;\r\n border-bottom: 3px solid #94d2bd;\r\n padding-bottom: 0.5rem;\r\n }\r\n #drug-infographic-container .section-intro {\r\n font-size: 1.125rem;\r\n color: #4A5568;\r\n max-width: 48rem;\r\n margin: 0 auto 2rem auto;\r\n }\r\n #drug-infographic-container .card {\r\n background-color: white;\r\n border-radius: 0.75rem;\r\n box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -4px rgba(0, 0, 0, 0.1);\r\n padding: 1.5rem;\r\n height: 100%;\r\n display: flex;\r\n flex-direction: column;\r\n }\r\n #drug-infographic-container .card-title {\r\n font-size: 1.5rem;\r\n font-weight: 600;\r\n color: #005f73;\r\n margin-bottom: 1rem;\r\n }\r\n #drug-infographic-container .card-text {\r\n font-size: 1rem;\r\n color: #4A5568;\r\n flex-grow: 1;\r\n margin-bottom: 1rem;\r\n }\r\n <\/style>\r\n<\/head>\r\n<body class=\"bg-[#f0f4f8] text-gray-800\">\r\n\r\n<div id=\"drug-infographic-container\">\r\n <header class=\"bg-[#001219] text-white py-8 px-4 text-center\">\r\n <h1 class=\"text-4xl md:text-5xl font-bold mb-2 text-[#94d2bd]\">L'\u00e9volution du paysage pharmaceutique en Europe<\/h1>\r\n <p class=\"text-lg md:text-xl max-w-3xl mx-auto text-gray-300\">Une analyse des chiffres cl\u00e9s, des menaces \u00e9mergentes et des d\u00e9fis de sant\u00e9 publique sur la base des donn\u00e9es de 2024.<\/p>\r\n <\/header>\r\n\r\n <main class=\"container mx-auto p-4 md:p-8\">\r\n \r\n <section class=\"mb-16 text-center\">\r\n <h2 class=\"section-title\">Une situation complexe et dynamique<\/h2>\r\n <p class=\"section-intro\">Le paysage europ\u00e9en de la drogue se caract\u00e9rise par une grande disponibilit\u00e9 des drogues \u00e9tablies et l'apparition de nouvelles substances psychoactives (NPS) puissantes. Cette dynamique cr\u00e9e des d\u00e9fis sans pr\u00e9c\u00e9dent pour la sant\u00e9 publique, exigeant des r\u00e9ponses adapt\u00e9es et solides sur tout le continent.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6\">\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">24M<\/div>\r\n <div class=\"stat-label\">Les adultes ont consomm\u00e9 du cannabis l'ann\u00e9e derni\u00e8re<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">419t<\/div>\r\n <div class=\"stat-label\">Saisies record de coca\u00efne en 2023<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">>1,000<\/div>\r\n <div class=\"stat-label\">Nouvelles substances psychoactives surveill\u00e9es<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">7 sur 10<\/div>\r\n <div class=\"stat-label\">Overdoses mortelles impliquant des opio\u00efdes<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Aper\u00e7u de la consommation de drogues illicites<\/h2>\r\n <p class=\"section-intro text-center\">Le cannabis reste de loin la drogue illicite la plus consomm\u00e9e, mais les stimulants et les opio\u00efdes pr\u00e9sentent des niveaux de nocivit\u00e9 disproportionn\u00e9s. La consommation est la plus r\u00e9pandue chez les jeunes adultes, bien que les cons\u00e9quences les plus graves soient souvent observ\u00e9es dans les cohortes plus \u00e2g\u00e9es, principalement masculines.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Consommation de drogues au cours de la derni\u00e8re ann\u00e9e chez les jeunes adultes (15-34)<\/h3>\r\n <p class=\"card-text\">Ce graphique illustre la pr\u00e9valence de la consommation des principales substances illicites chez les Europ\u00e9ens \u00e2g\u00e9s de 15 \u00e0 34 ans. Si la consommation de cannabis est tr\u00e8s r\u00e9pandue, celle de stimulants tels que la coca\u00efne et la MDMA est \u00e9galement importante dans cette tranche d'\u00e2ge, ce qui met en \u00e9vidence des domaines cl\u00e9s pour des efforts de pr\u00e9vention cibl\u00e9s.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"youngAdultsPrevalenceChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Premi\u00e8re demande de traitement<\/h3>\r\n <p class=\"card-text\">Ce graphique montre les principales raisons pour lesquelles les individus entrent pour la premi\u00e8re fois en traitement de la toxicomanie. L'augmentation des troubles li\u00e9s \u00e0 l'usage du cannabis (TAC) en tant que cause principale est une tendance critique de sant\u00e9 publique, signalant les cons\u00e9quences des produits \u00e0 forte puissance et l'\u00e9volution de la perception du risque.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"treatmentDemandChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Coca\u00efne : Un march\u00e9 en pleine expansion<\/h2>\r\n <p class=\"section-intro text-center\">La disponibilit\u00e9 de la coca\u00efne en Europe n'a jamais \u00e9t\u00e9 aussi \u00e9lev\u00e9e, en raison de l'augmentation de la production et de la sophistication du trafic. Cette hausse alimente non seulement l'augmentation de la consommation et des effets n\u00e9fastes sur la sant\u00e9, notamment la consommation de crack, mais aussi la criminalit\u00e9 et la violence li\u00e9es \u00e0 la drogue dans certaines r\u00e9gions.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Saisies record de coca\u00efne dans l'UE (tonnes)<\/h3>\r\n <p class=\"card-text\">Le volume de coca\u00efne saisi par les \u00c9tats membres de l'UE a atteint des niveaux sans pr\u00e9c\u00e9dent, augmentant pour la septi\u00e8me ann\u00e9e cons\u00e9cutive. Ce graphique illustre la croissance spectaculaire du trafic, les saisies passant de 323 tonnes en 2022 \u00e0 419 tonnes en 2023.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Analyse des eaux us\u00e9es : Points chauds de la coca\u00efne<\/h3>\r\n <p class=\"card-text\">Les donn\u00e9es relatives aux eaux us\u00e9es constituent une mesure objective de la consommation de drogues. Ce graphique met en \u00e9vidence l'\u00e9volution des r\u00e9sidus de coca\u00efne dans les eaux us\u00e9es entre 2023 et 2024 dans 72 villes europ\u00e9ennes, confirmant une consommation \u00e9lev\u00e9e et croissante, en particulier en Europe occidentale et m\u00e9ridionale.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineWastewaterChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Les opio\u00efdes : Une menace \u00e9volutive et puissante<\/h2>\r\n <p class=\"section-intro text-center\">Le march\u00e9 des opio\u00efdes est en train de subir une dangereuse transformation. Alors que l'h\u00e9ro\u00efne continue de causer des dommages importants au sein d'une population d'usagers vieillissante, la mont\u00e9e en puissance de nouveaux opio\u00efdes synth\u00e9tiques tr\u00e8s puissants, en particulier les nitaz\u00e8nes, repr\u00e9sente une menace aigu\u00eb et croissante d'overdose mortelle dans toute l'Europe.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Le double fardeau du traitement des opio\u00efdes<\/h3>\r\n <p class=\"card-text\">L'Europe est confront\u00e9e \u00e0 une \"double \u00e9pid\u00e9mie\" : fournir des soins \u00e0 long terme \u00e0 une population vieillissante d'h\u00e9ro\u00efnomanes traditionnels tout en r\u00e9pondant aux dangers aigus des nouveaux opio\u00efdes synth\u00e9tiques (ONS) comme les nitaz\u00e8nes. Ce graphique compare le grand nombre de clients suivant un traitement \u00e0 long terme aux agonistes opio\u00efdes (OAT) avec la forte augmentation des saisies de nitaz\u00e8nes puissants.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"opioidTreatmentVsThreatChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Facteurs de surdoses mortelles<\/h3>\r\n <p class=\"card-text\">Les opio\u00efdes sont les principales substances impliqu\u00e9es dans les d\u00e9c\u00e8s li\u00e9s \u00e0 la drogue. Cette visualisation illustre de mani\u00e8re frappante l'ampleur du probl\u00e8me : des opio\u00efdes \u00e9taient pr\u00e9sents dans 7 cas d'overdose mortelle sur 10 pour lesquels des donn\u00e9es toxicologiques \u00e9taient disponibles en 2023.<\/p>\r\n <div class=\"flex flex-col items-center justify-center h-full text-center mt-4\">\r\n <div class=\"text-8xl font-bold text-[#ae2012]\">70%<\/div>\r\n <div class=\"text-xl font-semibold text-[#005f73] mt-1\">des overdoses mortelles impliquent des opio\u00efdes<\/div>\r\n <div class=\"w-full max-w-sm bg-gray-200 rounded-full h-6 mt-6 flex overflow-hidden border border-gray-300\">\r\n <div class=\"bg-[#ae2012] h-full\" style=\"width: 70%;\"><\/div>\r\n <div class=\"bg-gray-300 h-full\" style=\"width: 30%;\"><\/div>\r\n <\/div>\r\n <div class=\"w-full max-w-sm flex justify-between text-sm mt-1 text-gray-600\">\r\n <span>Impliquant des opio\u00efdes<\/span>\r\n <span>Autre\/Non<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Le d\u00e9fi des nouvelles substances psychoactives (NPS)<\/h2>\r\n <p class=\"section-intro text-center\">Le march\u00e9 des NPS est une cible qui \u00e9volue rapidement, avec des volumes sans pr\u00e9c\u00e9dent de substances telles que les cathinones synth\u00e9tiques saisies et l'apparition constante de nouveaux compos\u00e9s. Cela cr\u00e9e un jeu du \"chat et de la souris\" pour les r\u00e9gulateurs et un risque important pour les utilisateurs qui peuvent, sans le savoir, consommer des produits chimiques puissants et dangereux.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Augmentation des saisies de cathinone synth\u00e9tique (tonnes)<\/h3>\r\n <p class=\"card-text\">Le march\u00e9 des cathinones de synth\u00e8se se d\u00e9veloppe rapidement, les saisies affichant une croissance exponentielle. De seulement 4,5 tonnes en 2021, la quantit\u00e9 saisie est pass\u00e9e \u00e0 au moins 37 tonnes en 2023, ce qui indique une importation massive en vrac et un march\u00e9 int\u00e9rieur en pleine expansion.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cathinoneSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Diversit\u00e9 des nouvelles substances d\u00e9tect\u00e9es (2024)<\/h3>\r\n <p class=\"card-text\">Rien qu'en 2024, 47 nouvelles substances ont \u00e9t\u00e9 signal\u00e9es pour la premi\u00e8re fois en Europe. Ce tableau d\u00e9compose les types de nouvelles drogues apparaissant, soulignant le nombre important de nouveaux cannabino\u00efdes synth\u00e9tiques, de cathinones et d'opio\u00efdes puissants \u00e0 base de nitaz\u00e8ne que les autorit\u00e9s surveillent.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"npsDiversityChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n \r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Du trafic mondial \u00e0 la production nationale<\/h2>\r\n <p class=\"section-intro text-center\">L'offre de drogue en Europe est un r\u00e9seau complexe d'itin\u00e9raires de trafic international et d'une production nationale croissante. Alors que les grands ports de Belgique, des Pays-Bas et d'Espagne restent les principaux points d'entr\u00e9e de la coca\u00efne, les laboratoires illicites de l'UE produisent de grandes quantit\u00e9s de drogues synth\u00e9tiques comme la MDMA et les amph\u00e9tamines.<\/p>\r\n <div class=\"bg-white rounded-lg shadow-lg p-6 md:p-8\">\r\n <div class=\"grid grid-cols-1 md:grid-cols-3 gap-8 items-center\">\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Trafic en Am\u00e9rique du Sud<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udf0e \u27a1\ufe0f \ud83d\udea2<\/p>\r\n <p>L'augmentation de la production de coca en Am\u00e9rique du Sud alimente les exp\u00e9ditions massives de coca\u00efne vers les principaux ports europ\u00e9ens (Anvers, Rotterdam, ports espagnols).<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-red-100 text-red-800 p-2 rounded\">Menace : Saisie record de 419 tonnes de coca\u00efne.<\/div>\r\n <\/div>\r\n \r\n <div class=\"text-gray-400 text-5xl font-bold text-center\">\r\n <span class=\"hidden md:block\">\u27a1\ufe0f<\/span>\r\n <span class=\"block md:hidden my-4\">\u2b07\ufe0f<\/span>\r\n <\/div>\r\n\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Production de m\u00e9dicaments de synth\u00e8se dans l'UE<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udfed \ud83e\uddea \ud83d\ude9a<\/p>\r\n <p>Des laboratoires situ\u00e9s principalement aux Pays-Bas, en Belgique, en Pologne et en Tch\u00e9quie produisent de grandes quantit\u00e9s de MDMA, d'amph\u00e9tamines et de cathinones pour le march\u00e9 europ\u00e9en.<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-yellow-100 text-yellow-800 p-2 rounded\">Pr\u00e9occupation : 36 laboratoires de MDMA et 93 laboratoires d'amph\u00e9tamine d\u00e9mantel\u00e9s en 2023.<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <\/main>\r\n\r\n <footer class=\"bg-[#001219] text-white text-center p-6 mt-8\">\r\n <p>Cette infographie est bas\u00e9e sur des donn\u00e9es provenant principalement de l'Observatoire europ\u00e9en des drogues et des toxicomanies (OEDT) pour la p\u00e9riode 2023-2024.<\/p>\r\n <p class=\"text-sm text-gray-400 mt-2\">Con\u00e7u pour fournir une vue d'ensemble de haut niveau d'une situation complexe et \u00e9volutive.<\/p>\r\n <\/footer>\r\n<\/div>\r\n\r\n<script>\r\n const initializeDrugInfographicCharts = () => {\r\n \/\/ A simple flag to prevent re-initialization, which can happen in some CMS environments\r\n if (window.drugChartInitialized) {\r\n return;\r\n }\r\n window.drugChartInitialized = true;\r\n\r\n const vibrantPalette = {\r\n blue: '#0a9396',\r\n teal: '#94d2bd',\r\n mint: '#e0fbfc',\r\n darkBlue: '#005f73',\r\n darkestBlue: '#001219',\r\n orange: '#ee9b00',\r\n red: '#ae2012',\r\n };\r\n\r\n const tooltipConfig = {\r\n plugins: {\r\n tooltip: {\r\n callbacks: {\r\n title: function(tooltipItems) {\r\n const item = tooltipItems[0];\r\n let label = item.chart.data.labels[item.dataIndex];\r\n if (Array.isArray(label)) {\r\n return label.join(' ');\r\n }\r\n return label;\r\n }\r\n }\r\n }\r\n }\r\n };\r\n\r\n function wrapLabel(str, maxWidth) {\r\n if (str.length <= maxWidth) return str;\r\n let words = str.split(' ');\r\n let lines = [];\r\n let currentLine = words[0];\r\n for (let i = 1; i < words.length; i++) {\r\n if ((currentLine.length + words[i].length + 1) < maxWidth) {\r\n currentLine += ' ' + words[i];\r\n } else {\r\n lines.push(currentLine);\r\n currentLine = words[i];\r\n }\r\n }\r\n lines.push(currentLine);\r\n return lines;\r\n }\r\n\r\n try {\r\n new Chart(document.getElementById('youngAdultsPrevalenceChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['Cannabis', 'Cocaine', 'MDMA', 'Amphetamines'],\r\n datasets: [{\r\n label: 'Last-Year Use (%)',\r\n data: [15.4, 2.6, 2.6, 1.6],\r\n backgroundColor: [vibrantPalette.blue, vibrantPalette.teal, vibrantPalette.orange, vibrantPalette.red],\r\n borderColor: vibrantPalette.darkestBlue,\r\n borderWidth: 1\r\n }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Prevalence (%)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating youngAdultsPrevalenceChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('treatmentDemandChart'), {\r\n type: 'doughnut',\r\n data: {\r\n labels: [ wrapLabel('Cannabis Use Disorder', 16), 'Opioids', 'Cocaine', 'Other' ],\r\n datasets: [{ data: [34, 23, 20, 23], backgroundColor: [vibrantPalette.blue, vibrantPalette.red, vibrantPalette.orange, vibrantPalette.teal], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating treatmentDemandChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineSeizuresChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [222, 323, 419], backgroundColor: vibrantPalette.orange, borderColor: vibrantPalette.darkestBlue, borderWidth: 1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineWastewaterChart'), {\r\n type: 'pie',\r\n data: {\r\n labels: ['Increase in Residues', 'No Change', 'Decrease'],\r\n datasets: [{ label: 'Cities (Total 72)', data: [39, 17, 16], backgroundColor: [vibrantPalette.red, vibrantPalette.teal, vibrantPalette.blue], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineWastewaterChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('opioidTreatmentVsThreatChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('Clients in Opioid Agonist Treatment', 16), wrapLabel('Nitazenes Seized (kg)', 16)],\r\n datasets: [ { label: '2022', data: [510000, 3], backgroundColor: vibrantPalette.teal, }, { label: '2023', data: [511000, 10], backgroundColor: vibrantPalette.blue, } ]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { type: 'logarithmic', beginAtZero: true, title: { display: true, text: 'Count \/ Kilograms (Log Scale)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating opioidTreatmentVsThreatChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('cathinoneSeizuresChart'), {\r\n type: 'line',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [4.5, 27, 37], fill: true, borderColor: vibrantPalette.red, backgroundColor: 'rgba(174, 32, 18, 0.2)', tension: 0.1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cathinoneSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('npsDiversityChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('New Cannabinoids*', 16), wrapLabel('New Cathinones', 16), wrapLabel('New Opioids (Nitazenes)', 16), 'Other NPS'],\r\n datasets: [{ label: 'New Substances Detected in 2024 (Total 47)', data: [15, 7, 7, 18], backgroundColor: [vibrantPalette.blue, vibrantPalette.orange, vibrantPalette.red, vibrantPalette.teal], }]\r\n },\r\n options: { indexAxis: 'y', responsive: true, maintainAspectRatio: false, scales: { x: { beginAtZero: true, title: { display: true, text: 'Number of New Substances' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false }, tooltip: { ...tooltipConfig.plugins.tooltip, footer: '*Cannabinoid data reflects 2022 reports as a recent high-water mark.' } } }\r\n });\r\n } catch(e) { console.error(\"Error creating npsDiversityChart:\", e); }\r\n };\r\n\r\n \/\/ This robustly waits for the DOM to be ready before trying to create the charts.\r\n if (document.readyState === 'loading') {\r\n document.addEventListener('DOMContentLoaded', initializeDrugInfographicCharts);\r\n } else {\r\n \/\/ DOMContentLoaded has already fired\r\n initializeDrugInfographicCharts();\r\n }\r\n<\/script>\r\n\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>La situation europ\u00e9enne en mati\u00e8re de drogues : Une infographie interactive L'\u00e9volution du paysage europ\u00e9en de la drogue Une analyse des chiffres cl\u00e9s, des menaces \u00e9mergentes et des [...]<\/p>","protected":false},"author":2,"featured_media":3816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[4,35],"tags":[99,102,101,95,97,61,98,100],"class_list":["post-3813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-addiction","category-drug-facts","tag-cocaine-trafficking-europe","tag-drug-crisis-europe","tag-drug-policy-eu","tag-drug-free-rehabilitation","tag-european-drug-trends","tag-narconon","tag-synthetic-drugs-europe","tag-youth-addiction-europe"],"acf":[],"yoast_head":"\n<title>Evolving Drug Landscape in Europe: Key Trends<\/title>\n<meta name=\"description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe's Evolving Drug Landscape\" \/>\n<meta property=\"og:description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/\" \/>\n<meta property=\"og:site_name\" content=\"Narconon Europe\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/narcononeu\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-08T18:52:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-07T08:30:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jacky Buensoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:site\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jacky Buensoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"author\":{\"name\":\"Jacky Buensoz\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\"},\"headline\":\"Europe’s Evolving Drug Landscape\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"wordCount\":792,\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"keywords\":[\"Cocaine trafficking Europe\",\"Drug crisis Europe\",\"Drug policy EU\",\"Drug-free rehabilitation\",\"European drug trends\",\"Narconon\",\"Synthetic drugs Europe\",\"Youth addiction Europe\"],\"articleSection\":[\"Addiction\",\"Drug Facts\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"url\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"name\":\"Evolving Drug Landscape in Europe: Key Trends\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"description\":\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"width\":1280,\"height\":896,\"caption\":\"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.narconon.online\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe’s Evolving Drug Landscape\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.narconon.online\/#website\",\"url\":\"https:\/\/www.narconon.online\/\",\"name\":\"Narconon Europe\",\"description\":\"Drug Free For Good\",\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.narconon.online\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.narconon.online\/#organization\",\"name\":\"Narconon Europe\",\"url\":\"https:\/\/www.narconon.online\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"width\":2000,\"height\":707,\"caption\":\"Narconon Europe\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/narcononeu\",\"https:\/\/x.com\/NARCONONEurope\",\"https:\/\/www.instagram.com\/narconon.europe\/\",\"https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA\",\"https:\/\/www.tiktok.com\/@narconon.europe\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\",\"name\":\"Jacky Buensoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"caption\":\"Jacky Buensoz\"},\"description\":\"I have personally experienced various drugs before making the life-changing decision to turn things around. In 1993, I completed the Narconon program in Plans-sur-Bex, Switzerland, a pivotal experience that set me on a new path. Since then, I have dedicated my life to helping and rehabilitating addicts, gaining decades of experience in prevention, rehabilitation, and family support. With years of hands-on experience, I have been serving as the Director of Narconon Europe for the past four years. My mission is to provide effective solutions to help those struggling with addiction and to support their loved ones throughout this transformative journey. My goal is to bring about real change, sharing my expertise and guiding individuals toward a life free from addiction.\"}]}<\/script>\n","yoast_head_json":{"title":"\u00c9volution du paysage pharmaceutique en Europe : Principales tendances","description":"Explorez l'\u00e9volution du paysage pharmaceutique en Europe gr\u00e2ce aux donn\u00e9es de 2024 sur les menaces \u00e9mergentes et les d\u00e9fis de sant\u00e9 publique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/","og_locale":"fr_FR","og_type":"article","og_title":"Europe's Evolving Drug Landscape","og_description":"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.","og_url":"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/","og_site_name":"Narconon Europe","article_publisher":"https:\/\/www.facebook.com\/narcononeu","article_published_time":"2025-06-08T18:52:34+00:00","article_modified_time":"2025-07-07T08:30:27+00:00","og_image":[{"width":1280,"height":896,"url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","type":"image\/webp"}],"author":"Jacky Buensoz","twitter_card":"summary_large_image","twitter_creator":"@NARCONONEurope","twitter_site":"@NARCONONEurope","twitter_misc":{"\u00c9crit par":"Jacky Buensoz","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article","isPartOf":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"author":{"name":"Jacky Buensoz","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46"},"headline":"Europe’s Evolving Drug Landscape","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"wordCount":792,"publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","keywords":["Cocaine trafficking Europe","Drug crisis Europe","Drug policy EU","Drug-free rehabilitation","European drug trends","Narconon","Synthetic drugs Europe","Youth addiction Europe"],"articleSection":["Addiction","Drug Facts"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","url":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","name":"\u00c9volution du paysage pharmaceutique en Europe : Principales tendances","isPartOf":{"@id":"https:\/\/www.narconon.online\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","description":"Explorez l'\u00e9volution du paysage pharmaceutique en Europe gr\u00e2ce aux donn\u00e9es de 2024 sur les menaces \u00e9mergentes et les d\u00e9fis de sant\u00e9 publique.","breadcrumb":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","width":1280,"height":896,"caption":"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances"},{"@type":"BreadcrumbList","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.narconon.online\/"},{"@type":"ListItem","position":2,"name":"Europe’s Evolving Drug Landscape"}]},{"@type":"WebSite","@id":"https:\/\/www.narconon.online\/#website","url":"https:\/\/www.narconon.online\/","name":"Narconon Europe","description":"Lib\u00e9r\u00e9 de la drogue pour de bon","publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.narconon.online\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.narconon.online\/#organization","name":"Narconon Europe","url":"https:\/\/www.narconon.online\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","width":2000,"height":707,"caption":"Narconon Europe"},"image":{"@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/narcononeu","https:\/\/x.com\/NARCONONEurope","https:\/\/www.instagram.com\/narconon.europe\/","https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA","https:\/\/www.tiktok.com\/@narconon.europe"]},{"@type":"Person","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46","name":"Jacky Buensoz","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","caption":"Jacky Buensoz"},"description":"J'ai personnellement fait l'exp\u00e9rience de diverses drogues avant de prendre la d\u00e9cision de changer de vie. En 1993, j'ai suivi le programme Narconon aux Plans-sur-Bex, en Suisse, une exp\u00e9rience d\u00e9terminante qui m'a mis sur une nouvelle voie. Depuis lors, j'ai consacr\u00e9 ma vie \u00e0 aider et \u00e0 r\u00e9habiliter les toxicomanes, en acqu\u00e9rant des d\u00e9cennies d'exp\u00e9rience en mati\u00e8re de pr\u00e9vention, de r\u00e9habilitation et de soutien aux familles. Forte de ces ann\u00e9es d'exp\u00e9rience pratique, je suis directrice de Narconon Europe depuis quatre ans. Ma mission est de fournir des solutions efficaces pour aider ceux qui luttent contre la d\u00e9pendance et pour soutenir leurs proches tout au long de ce voyage transformateur. Mon objectif est d'apporter un r\u00e9el changement, en partageant mon expertise et en guidant les individus vers une vie lib\u00e9r\u00e9e de la d\u00e9pendance."}]}},"_links":{"self":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts\/3813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/comments?post=3813"}],"version-history":[{"count":20,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts\/3813\/revisions"}],"predecessor-version":[{"id":3845,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts\/3813\/revisions\/3845"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/media\/3816"}],"wp:attachment":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/media?parent=3813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/categories?post=3813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/tags?post=3813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\n\t\t\t\t

\n\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\t\r\n\r\n\r\n \r\n \r\n La situation europ\u00e9enne en mati\u00e8re de drogues : Une infographie interactive<\/title>\r\n <script src=\"https:\/\/cdn.tailwindcss.com\"><\/script>\r\n <script src=\"https:\/\/cdn.jsdelivr.net\/npm\/chart.js\"><\/script>\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\r\n <link href=\"https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@400;600;700&display=swap\" rel=\"stylesheet\">\r\n <style>\r\n #drug-infographic-container body {\r\n font-family: 'Inter', sans-serif;\r\n }\r\n #drug-infographic-container .chart-container {\r\n position: relative;\r\n width: 100%;\r\n max-width: 600px;\r\n margin-left: auto;\r\n margin-right: auto;\r\n height: 350px;\r\n max-height: 400px;\r\n }\r\n @media (min-width: 768px) {\r\n #drug-infographic-container .chart-container {\r\n height: 400px;\r\n }\r\n }\r\n #drug-infographic-container .stat-card {\r\n background-color: #ffffff;\r\n border-radius: 0.75rem;\r\n padding: 1.5rem;\r\n box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -2px rgba(0, 0, 0, 0.1);\r\n text-align: center;\r\n border-left: 5px solid #005f73;\r\n }\r\n #drug-infographic-container .stat-number {\r\n font-size: 2.5rem;\r\n font-weight: 700;\r\n color: #001219;\r\n }\r\n #drug-infographic-container .stat-label {\r\n font-size: 1rem;\r\n color: #0a9396;\r\n margin-top: 0.5rem;\r\n }\r\n #drug-infographic-container .section-title {\r\n font-size: 2.25rem;\r\n font-weight: 700;\r\n color: #001219;\r\n margin-bottom: 1rem;\r\n border-bottom: 3px solid #94d2bd;\r\n padding-bottom: 0.5rem;\r\n }\r\n #drug-infographic-container .section-intro {\r\n font-size: 1.125rem;\r\n color: #4A5568;\r\n max-width: 48rem;\r\n margin: 0 auto 2rem auto;\r\n }\r\n #drug-infographic-container .card {\r\n background-color: white;\r\n border-radius: 0.75rem;\r\n box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -4px rgba(0, 0, 0, 0.1);\r\n padding: 1.5rem;\r\n height: 100%;\r\n display: flex;\r\n flex-direction: column;\r\n }\r\n #drug-infographic-container .card-title {\r\n font-size: 1.5rem;\r\n font-weight: 600;\r\n color: #005f73;\r\n margin-bottom: 1rem;\r\n }\r\n #drug-infographic-container .card-text {\r\n font-size: 1rem;\r\n color: #4A5568;\r\n flex-grow: 1;\r\n margin-bottom: 1rem;\r\n }\r\n <\/style>\r\n<\/head>\r\n<body class=\"bg-[#f0f4f8] text-gray-800\">\r\n\r\n<div id=\"drug-infographic-container\">\r\n <header class=\"bg-[#001219] text-white py-8 px-4 text-center\">\r\n <h1 class=\"text-4xl md:text-5xl font-bold mb-2 text-[#94d2bd]\">L'\u00e9volution du paysage pharmaceutique en Europe<\/h1>\r\n <p class=\"text-lg md:text-xl max-w-3xl mx-auto text-gray-300\">Une analyse des chiffres cl\u00e9s, des menaces \u00e9mergentes et des d\u00e9fis de sant\u00e9 publique sur la base des donn\u00e9es de 2024.<\/p>\r\n <\/header>\r\n\r\n <main class=\"container mx-auto p-4 md:p-8\">\r\n \r\n <section class=\"mb-16 text-center\">\r\n <h2 class=\"section-title\">Une situation complexe et dynamique<\/h2>\r\n <p class=\"section-intro\">Le paysage europ\u00e9en de la drogue se caract\u00e9rise par une grande disponibilit\u00e9 des drogues \u00e9tablies et l'apparition de nouvelles substances psychoactives (NPS) puissantes. Cette dynamique cr\u00e9e des d\u00e9fis sans pr\u00e9c\u00e9dent pour la sant\u00e9 publique, exigeant des r\u00e9ponses adapt\u00e9es et solides sur tout le continent.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6\">\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">24M<\/div>\r\n <div class=\"stat-label\">Les adultes ont consomm\u00e9 du cannabis l'ann\u00e9e derni\u00e8re<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">419t<\/div>\r\n <div class=\"stat-label\">Saisies record de coca\u00efne en 2023<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">>1,000<\/div>\r\n <div class=\"stat-label\">Nouvelles substances psychoactives surveill\u00e9es<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">7 sur 10<\/div>\r\n <div class=\"stat-label\">Overdoses mortelles impliquant des opio\u00efdes<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Aper\u00e7u de la consommation de drogues illicites<\/h2>\r\n <p class=\"section-intro text-center\">Le cannabis reste de loin la drogue illicite la plus consomm\u00e9e, mais les stimulants et les opio\u00efdes pr\u00e9sentent des niveaux de nocivit\u00e9 disproportionn\u00e9s. La consommation est la plus r\u00e9pandue chez les jeunes adultes, bien que les cons\u00e9quences les plus graves soient souvent observ\u00e9es dans les cohortes plus \u00e2g\u00e9es, principalement masculines.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Consommation de drogues au cours de la derni\u00e8re ann\u00e9e chez les jeunes adultes (15-34)<\/h3>\r\n <p class=\"card-text\">Ce graphique illustre la pr\u00e9valence de la consommation des principales substances illicites chez les Europ\u00e9ens \u00e2g\u00e9s de 15 \u00e0 34 ans. Si la consommation de cannabis est tr\u00e8s r\u00e9pandue, celle de stimulants tels que la coca\u00efne et la MDMA est \u00e9galement importante dans cette tranche d'\u00e2ge, ce qui met en \u00e9vidence des domaines cl\u00e9s pour des efforts de pr\u00e9vention cibl\u00e9s.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"youngAdultsPrevalenceChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Premi\u00e8re demande de traitement<\/h3>\r\n <p class=\"card-text\">Ce graphique montre les principales raisons pour lesquelles les individus entrent pour la premi\u00e8re fois en traitement de la toxicomanie. L'augmentation des troubles li\u00e9s \u00e0 l'usage du cannabis (TAC) en tant que cause principale est une tendance critique de sant\u00e9 publique, signalant les cons\u00e9quences des produits \u00e0 forte puissance et l'\u00e9volution de la perception du risque.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"treatmentDemandChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Coca\u00efne : Un march\u00e9 en pleine expansion<\/h2>\r\n <p class=\"section-intro text-center\">La disponibilit\u00e9 de la coca\u00efne en Europe n'a jamais \u00e9t\u00e9 aussi \u00e9lev\u00e9e, en raison de l'augmentation de la production et de la sophistication du trafic. Cette hausse alimente non seulement l'augmentation de la consommation et des effets n\u00e9fastes sur la sant\u00e9, notamment la consommation de crack, mais aussi la criminalit\u00e9 et la violence li\u00e9es \u00e0 la drogue dans certaines r\u00e9gions.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Saisies record de coca\u00efne dans l'UE (tonnes)<\/h3>\r\n <p class=\"card-text\">Le volume de coca\u00efne saisi par les \u00c9tats membres de l'UE a atteint des niveaux sans pr\u00e9c\u00e9dent, augmentant pour la septi\u00e8me ann\u00e9e cons\u00e9cutive. Ce graphique illustre la croissance spectaculaire du trafic, les saisies passant de 323 tonnes en 2022 \u00e0 419 tonnes en 2023.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Analyse des eaux us\u00e9es : Points chauds de la coca\u00efne<\/h3>\r\n <p class=\"card-text\">Les donn\u00e9es relatives aux eaux us\u00e9es constituent une mesure objective de la consommation de drogues. Ce graphique met en \u00e9vidence l'\u00e9volution des r\u00e9sidus de coca\u00efne dans les eaux us\u00e9es entre 2023 et 2024 dans 72 villes europ\u00e9ennes, confirmant une consommation \u00e9lev\u00e9e et croissante, en particulier en Europe occidentale et m\u00e9ridionale.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineWastewaterChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Les opio\u00efdes : Une menace \u00e9volutive et puissante<\/h2>\r\n <p class=\"section-intro text-center\">Le march\u00e9 des opio\u00efdes est en train de subir une dangereuse transformation. Alors que l'h\u00e9ro\u00efne continue de causer des dommages importants au sein d'une population d'usagers vieillissante, la mont\u00e9e en puissance de nouveaux opio\u00efdes synth\u00e9tiques tr\u00e8s puissants, en particulier les nitaz\u00e8nes, repr\u00e9sente une menace aigu\u00eb et croissante d'overdose mortelle dans toute l'Europe.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Le double fardeau du traitement des opio\u00efdes<\/h3>\r\n <p class=\"card-text\">L'Europe est confront\u00e9e \u00e0 une \"double \u00e9pid\u00e9mie\" : fournir des soins \u00e0 long terme \u00e0 une population vieillissante d'h\u00e9ro\u00efnomanes traditionnels tout en r\u00e9pondant aux dangers aigus des nouveaux opio\u00efdes synth\u00e9tiques (ONS) comme les nitaz\u00e8nes. Ce graphique compare le grand nombre de clients suivant un traitement \u00e0 long terme aux agonistes opio\u00efdes (OAT) avec la forte augmentation des saisies de nitaz\u00e8nes puissants.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"opioidTreatmentVsThreatChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Facteurs de surdoses mortelles<\/h3>\r\n <p class=\"card-text\">Les opio\u00efdes sont les principales substances impliqu\u00e9es dans les d\u00e9c\u00e8s li\u00e9s \u00e0 la drogue. Cette visualisation illustre de mani\u00e8re frappante l'ampleur du probl\u00e8me : des opio\u00efdes \u00e9taient pr\u00e9sents dans 7 cas d'overdose mortelle sur 10 pour lesquels des donn\u00e9es toxicologiques \u00e9taient disponibles en 2023.<\/p>\r\n <div class=\"flex flex-col items-center justify-center h-full text-center mt-4\">\r\n <div class=\"text-8xl font-bold text-[#ae2012]\">70%<\/div>\r\n <div class=\"text-xl font-semibold text-[#005f73] mt-1\">des overdoses mortelles impliquent des opio\u00efdes<\/div>\r\n <div class=\"w-full max-w-sm bg-gray-200 rounded-full h-6 mt-6 flex overflow-hidden border border-gray-300\">\r\n <div class=\"bg-[#ae2012] h-full\" style=\"width: 70%;\"><\/div>\r\n <div class=\"bg-gray-300 h-full\" style=\"width: 30%;\"><\/div>\r\n <\/div>\r\n <div class=\"w-full max-w-sm flex justify-between text-sm mt-1 text-gray-600\">\r\n <span>Impliquant des opio\u00efdes<\/span>\r\n <span>Autre\/Non<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Le d\u00e9fi des nouvelles substances psychoactives (NPS)<\/h2>\r\n <p class=\"section-intro text-center\">Le march\u00e9 des NPS est une cible qui \u00e9volue rapidement, avec des volumes sans pr\u00e9c\u00e9dent de substances telles que les cathinones synth\u00e9tiques saisies et l'apparition constante de nouveaux compos\u00e9s. Cela cr\u00e9e un jeu du \"chat et de la souris\" pour les r\u00e9gulateurs et un risque important pour les utilisateurs qui peuvent, sans le savoir, consommer des produits chimiques puissants et dangereux.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Augmentation des saisies de cathinone synth\u00e9tique (tonnes)<\/h3>\r\n <p class=\"card-text\">Le march\u00e9 des cathinones de synth\u00e8se se d\u00e9veloppe rapidement, les saisies affichant une croissance exponentielle. De seulement 4,5 tonnes en 2021, la quantit\u00e9 saisie est pass\u00e9e \u00e0 au moins 37 tonnes en 2023, ce qui indique une importation massive en vrac et un march\u00e9 int\u00e9rieur en pleine expansion.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cathinoneSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Diversit\u00e9 des nouvelles substances d\u00e9tect\u00e9es (2024)<\/h3>\r\n <p class=\"card-text\">Rien qu'en 2024, 47 nouvelles substances ont \u00e9t\u00e9 signal\u00e9es pour la premi\u00e8re fois en Europe. Ce tableau d\u00e9compose les types de nouvelles drogues apparaissant, soulignant le nombre important de nouveaux cannabino\u00efdes synth\u00e9tiques, de cathinones et d'opio\u00efdes puissants \u00e0 base de nitaz\u00e8ne que les autorit\u00e9s surveillent.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"npsDiversityChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n \r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Du trafic mondial \u00e0 la production nationale<\/h2>\r\n <p class=\"section-intro text-center\">L'offre de drogue en Europe est un r\u00e9seau complexe d'itin\u00e9raires de trafic international et d'une production nationale croissante. Alors que les grands ports de Belgique, des Pays-Bas et d'Espagne restent les principaux points d'entr\u00e9e de la coca\u00efne, les laboratoires illicites de l'UE produisent de grandes quantit\u00e9s de drogues synth\u00e9tiques comme la MDMA et les amph\u00e9tamines.<\/p>\r\n <div class=\"bg-white rounded-lg shadow-lg p-6 md:p-8\">\r\n <div class=\"grid grid-cols-1 md:grid-cols-3 gap-8 items-center\">\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Trafic en Am\u00e9rique du Sud<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udf0e \u27a1\ufe0f \ud83d\udea2<\/p>\r\n <p>L'augmentation de la production de coca en Am\u00e9rique du Sud alimente les exp\u00e9ditions massives de coca\u00efne vers les principaux ports europ\u00e9ens (Anvers, Rotterdam, ports espagnols).<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-red-100 text-red-800 p-2 rounded\">Menace : Saisie record de 419 tonnes de coca\u00efne.<\/div>\r\n <\/div>\r\n \r\n <div class=\"text-gray-400 text-5xl font-bold text-center\">\r\n <span class=\"hidden md:block\">\u27a1\ufe0f<\/span>\r\n <span class=\"block md:hidden my-4\">\u2b07\ufe0f<\/span>\r\n <\/div>\r\n\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Production de m\u00e9dicaments de synth\u00e8se dans l'UE<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udfed \ud83e\uddea \ud83d\ude9a<\/p>\r\n <p>Des laboratoires situ\u00e9s principalement aux Pays-Bas, en Belgique, en Pologne et en Tch\u00e9quie produisent de grandes quantit\u00e9s de MDMA, d'amph\u00e9tamines et de cathinones pour le march\u00e9 europ\u00e9en.<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-yellow-100 text-yellow-800 p-2 rounded\">Pr\u00e9occupation : 36 laboratoires de MDMA et 93 laboratoires d'amph\u00e9tamine d\u00e9mantel\u00e9s en 2023.<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <\/main>\r\n\r\n <footer class=\"bg-[#001219] text-white text-center p-6 mt-8\">\r\n <p>Cette infographie est bas\u00e9e sur des donn\u00e9es provenant principalement de l'Observatoire europ\u00e9en des drogues et des toxicomanies (OEDT) pour la p\u00e9riode 2023-2024.<\/p>\r\n <p class=\"text-sm text-gray-400 mt-2\">Con\u00e7u pour fournir une vue d'ensemble de haut niveau d'une situation complexe et \u00e9volutive.<\/p>\r\n <\/footer>\r\n<\/div>\r\n\r\n<script>\r\n const initializeDrugInfographicCharts = () => {\r\n \/\/ A simple flag to prevent re-initialization, which can happen in some CMS environments\r\n if (window.drugChartInitialized) {\r\n return;\r\n }\r\n window.drugChartInitialized = true;\r\n\r\n const vibrantPalette = {\r\n blue: '#0a9396',\r\n teal: '#94d2bd',\r\n mint: '#e0fbfc',\r\n darkBlue: '#005f73',\r\n darkestBlue: '#001219',\r\n orange: '#ee9b00',\r\n red: '#ae2012',\r\n };\r\n\r\n const tooltipConfig = {\r\n plugins: {\r\n tooltip: {\r\n callbacks: {\r\n title: function(tooltipItems) {\r\n const item = tooltipItems[0];\r\n let label = item.chart.data.labels[item.dataIndex];\r\n if (Array.isArray(label)) {\r\n return label.join(' ');\r\n }\r\n return label;\r\n }\r\n }\r\n }\r\n }\r\n };\r\n\r\n function wrapLabel(str, maxWidth) {\r\n if (str.length <= maxWidth) return str;\r\n let words = str.split(' ');\r\n let lines = [];\r\n let currentLine = words[0];\r\n for (let i = 1; i < words.length; i++) {\r\n if ((currentLine.length + words[i].length + 1) < maxWidth) {\r\n currentLine += ' ' + words[i];\r\n } else {\r\n lines.push(currentLine);\r\n currentLine = words[i];\r\n }\r\n }\r\n lines.push(currentLine);\r\n return lines;\r\n }\r\n\r\n try {\r\n new Chart(document.getElementById('youngAdultsPrevalenceChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['Cannabis', 'Cocaine', 'MDMA', 'Amphetamines'],\r\n datasets: [{\r\n label: 'Last-Year Use (%)',\r\n data: [15.4, 2.6, 2.6, 1.6],\r\n backgroundColor: [vibrantPalette.blue, vibrantPalette.teal, vibrantPalette.orange, vibrantPalette.red],\r\n borderColor: vibrantPalette.darkestBlue,\r\n borderWidth: 1\r\n }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Prevalence (%)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating youngAdultsPrevalenceChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('treatmentDemandChart'), {\r\n type: 'doughnut',\r\n data: {\r\n labels: [ wrapLabel('Cannabis Use Disorder', 16), 'Opioids', 'Cocaine', 'Other' ],\r\n datasets: [{ data: [34, 23, 20, 23], backgroundColor: [vibrantPalette.blue, vibrantPalette.red, vibrantPalette.orange, vibrantPalette.teal], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating treatmentDemandChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineSeizuresChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [222, 323, 419], backgroundColor: vibrantPalette.orange, borderColor: vibrantPalette.darkestBlue, borderWidth: 1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineWastewaterChart'), {\r\n type: 'pie',\r\n data: {\r\n labels: ['Increase in Residues', 'No Change', 'Decrease'],\r\n datasets: [{ label: 'Cities (Total 72)', data: [39, 17, 16], backgroundColor: [vibrantPalette.red, vibrantPalette.teal, vibrantPalette.blue], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineWastewaterChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('opioidTreatmentVsThreatChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('Clients in Opioid Agonist Treatment', 16), wrapLabel('Nitazenes Seized (kg)', 16)],\r\n datasets: [ { label: '2022', data: [510000, 3], backgroundColor: vibrantPalette.teal, }, { label: '2023', data: [511000, 10], backgroundColor: vibrantPalette.blue, } ]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { type: 'logarithmic', beginAtZero: true, title: { display: true, text: 'Count \/ Kilograms (Log Scale)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating opioidTreatmentVsThreatChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('cathinoneSeizuresChart'), {\r\n type: 'line',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [4.5, 27, 37], fill: true, borderColor: vibrantPalette.red, backgroundColor: 'rgba(174, 32, 18, 0.2)', tension: 0.1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cathinoneSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('npsDiversityChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('New Cannabinoids*', 16), wrapLabel('New Cathinones', 16), wrapLabel('New Opioids (Nitazenes)', 16), 'Other NPS'],\r\n datasets: [{ label: 'New Substances Detected in 2024 (Total 47)', data: [15, 7, 7, 18], backgroundColor: [vibrantPalette.blue, vibrantPalette.orange, vibrantPalette.red, vibrantPalette.teal], }]\r\n },\r\n options: { indexAxis: 'y', responsive: true, maintainAspectRatio: false, scales: { x: { beginAtZero: true, title: { display: true, text: 'Number of New Substances' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false }, tooltip: { ...tooltipConfig.plugins.tooltip, footer: '*Cannabinoid data reflects 2022 reports as a recent high-water mark.' } } }\r\n });\r\n } catch(e) { console.error(\"Error creating npsDiversityChart:\", e); }\r\n };\r\n\r\n \/\/ This robustly waits for the DOM to be ready before trying to create the charts.\r\n if (document.readyState === 'loading') {\r\n document.addEventListener('DOMContentLoaded', initializeDrugInfographicCharts);\r\n } else {\r\n \/\/ DOMContentLoaded has already fired\r\n initializeDrugInfographicCharts();\r\n }\r\n<\/script>\r\n\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>La situation europ\u00e9enne en mati\u00e8re de drogues : Une infographie interactive L'\u00e9volution du paysage europ\u00e9en de la drogue Une analyse des chiffres cl\u00e9s, des menaces \u00e9mergentes et des [...]<\/p>","protected":false},"author":2,"featured_media":3816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[4,35],"tags":[99,102,101,95,97,61,98,100],"class_list":["post-3813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-addiction","category-drug-facts","tag-cocaine-trafficking-europe","tag-drug-crisis-europe","tag-drug-policy-eu","tag-drug-free-rehabilitation","tag-european-drug-trends","tag-narconon","tag-synthetic-drugs-europe","tag-youth-addiction-europe"],"acf":[],"yoast_head":"\n<title>Evolving Drug Landscape in Europe: Key Trends<\/title>\n<meta name=\"description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe's Evolving Drug Landscape\" \/>\n<meta property=\"og:description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/\" \/>\n<meta property=\"og:site_name\" content=\"Narconon Europe\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/narcononeu\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-08T18:52:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-07T08:30:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jacky Buensoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:site\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jacky Buensoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"author\":{\"name\":\"Jacky Buensoz\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\"},\"headline\":\"Europe’s Evolving Drug Landscape\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"wordCount\":792,\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"keywords\":[\"Cocaine trafficking Europe\",\"Drug crisis Europe\",\"Drug policy EU\",\"Drug-free rehabilitation\",\"European drug trends\",\"Narconon\",\"Synthetic drugs Europe\",\"Youth addiction Europe\"],\"articleSection\":[\"Addiction\",\"Drug Facts\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"url\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"name\":\"Evolving Drug Landscape in Europe: Key Trends\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"description\":\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"width\":1280,\"height\":896,\"caption\":\"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.narconon.online\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe’s Evolving Drug Landscape\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.narconon.online\/#website\",\"url\":\"https:\/\/www.narconon.online\/\",\"name\":\"Narconon Europe\",\"description\":\"Drug Free For Good\",\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.narconon.online\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.narconon.online\/#organization\",\"name\":\"Narconon Europe\",\"url\":\"https:\/\/www.narconon.online\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"width\":2000,\"height\":707,\"caption\":\"Narconon Europe\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/narcononeu\",\"https:\/\/x.com\/NARCONONEurope\",\"https:\/\/www.instagram.com\/narconon.europe\/\",\"https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA\",\"https:\/\/www.tiktok.com\/@narconon.europe\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\",\"name\":\"Jacky Buensoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"caption\":\"Jacky Buensoz\"},\"description\":\"I have personally experienced various drugs before making the life-changing decision to turn things around. In 1993, I completed the Narconon program in Plans-sur-Bex, Switzerland, a pivotal experience that set me on a new path. Since then, I have dedicated my life to helping and rehabilitating addicts, gaining decades of experience in prevention, rehabilitation, and family support. With years of hands-on experience, I have been serving as the Director of Narconon Europe for the past four years. My mission is to provide effective solutions to help those struggling with addiction and to support their loved ones throughout this transformative journey. My goal is to bring about real change, sharing my expertise and guiding individuals toward a life free from addiction.\"}]}<\/script>\n","yoast_head_json":{"title":"\u00c9volution du paysage pharmaceutique en Europe : Principales tendances","description":"Explorez l'\u00e9volution du paysage pharmaceutique en Europe gr\u00e2ce aux donn\u00e9es de 2024 sur les menaces \u00e9mergentes et les d\u00e9fis de sant\u00e9 publique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/","og_locale":"fr_FR","og_type":"article","og_title":"Europe's Evolving Drug Landscape","og_description":"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.","og_url":"https:\/\/www.narconon.online\/fr\/leurope-un-paysage-pharmaceutique-en-evolution\/","og_site_name":"Narconon Europe","article_publisher":"https:\/\/www.facebook.com\/narcononeu","article_published_time":"2025-06-08T18:52:34+00:00","article_modified_time":"2025-07-07T08:30:27+00:00","og_image":[{"width":1280,"height":896,"url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","type":"image\/webp"}],"author":"Jacky Buensoz","twitter_card":"summary_large_image","twitter_creator":"@NARCONONEurope","twitter_site":"@NARCONONEurope","twitter_misc":{"\u00c9crit par":"Jacky Buensoz","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article","isPartOf":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"author":{"name":"Jacky Buensoz","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46"},"headline":"Europe’s Evolving Drug Landscape","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"wordCount":792,"publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","keywords":["Cocaine trafficking Europe","Drug crisis Europe","Drug policy EU","Drug-free rehabilitation","European drug trends","Narconon","Synthetic drugs Europe","Youth addiction Europe"],"articleSection":["Addiction","Drug Facts"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","url":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","name":"\u00c9volution du paysage pharmaceutique en Europe : Principales tendances","isPartOf":{"@id":"https:\/\/www.narconon.online\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","description":"Explorez l'\u00e9volution du paysage pharmaceutique en Europe gr\u00e2ce aux donn\u00e9es de 2024 sur les menaces \u00e9mergentes et les d\u00e9fis de sant\u00e9 publique.","breadcrumb":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","width":1280,"height":896,"caption":"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances"},{"@type":"BreadcrumbList","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.narconon.online\/"},{"@type":"ListItem","position":2,"name":"Europe’s Evolving Drug Landscape"}]},{"@type":"WebSite","@id":"https:\/\/www.narconon.online\/#website","url":"https:\/\/www.narconon.online\/","name":"Narconon Europe","description":"Lib\u00e9r\u00e9 de la drogue pour de bon","publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.narconon.online\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.narconon.online\/#organization","name":"Narconon Europe","url":"https:\/\/www.narconon.online\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","width":2000,"height":707,"caption":"Narconon Europe"},"image":{"@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/narcononeu","https:\/\/x.com\/NARCONONEurope","https:\/\/www.instagram.com\/narconon.europe\/","https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA","https:\/\/www.tiktok.com\/@narconon.europe"]},{"@type":"Person","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46","name":"Jacky Buensoz","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","caption":"Jacky Buensoz"},"description":"J'ai personnellement fait l'exp\u00e9rience de diverses drogues avant de prendre la d\u00e9cision de changer de vie. En 1993, j'ai suivi le programme Narconon aux Plans-sur-Bex, en Suisse, une exp\u00e9rience d\u00e9terminante qui m'a mis sur une nouvelle voie. Depuis lors, j'ai consacr\u00e9 ma vie \u00e0 aider et \u00e0 r\u00e9habiliter les toxicomanes, en acqu\u00e9rant des d\u00e9cennies d'exp\u00e9rience en mati\u00e8re de pr\u00e9vention, de r\u00e9habilitation et de soutien aux familles. Forte de ces ann\u00e9es d'exp\u00e9rience pratique, je suis directrice de Narconon Europe depuis quatre ans. Ma mission est de fournir des solutions efficaces pour aider ceux qui luttent contre la d\u00e9pendance et pour soutenir leurs proches tout au long de ce voyage transformateur. Mon objectif est d'apporter un r\u00e9el changement, en partageant mon expertise et en guidant les individus vers une vie lib\u00e9r\u00e9e de la d\u00e9pendance."}]}},"_links":{"self":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts\/3813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/comments?post=3813"}],"version-history":[{"count":20,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts\/3813\/revisions"}],"predecessor-version":[{"id":3845,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/posts\/3813\/revisions\/3845"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/media\/3816"}],"wp:attachment":[{"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/media?parent=3813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/categories?post=3813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.narconon.online\/fr\/wp-json\/wp\/v2\/tags?post=3813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}